![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/16/2883368/28889/en/Fortress-Biotech-to-Participate-in-the-Alliance-Global-Partners-A-G-P-Virtual-Healthcare-Company-Showcase.html
https://www.globenewswire.com/news-release/2024/05/15/2882920/28889/en/Fortress-Biotech-Reports-First-Quarter-2024-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com/news-release/2024/05/14/2881391/28889/en/Fortress-Biotech-Announces-First-Patient-Dosed-in-Multi-Center-Phase-2-Study-of-Triplex-for-Control-of-CMV-in-Patients-Undergoing-Liver-Transplantation.html
https://www.globenewswire.com/news-release/2024/03/28/2854477/28889/en/Fortress-Biotech-Reports-2023-Financial-Results-and-Recent-Corporate-Highlights.html
https://www.globenewswire.com//news-release/2024/03/12/2844540/28889/en/Fortress-Biotech-to-Participate-in-36th-Annual-ROTH-Conference.html
https://www.globenewswire.com//news-release/2024/03/04/2839612/28889/en/Fortress-Biotech-and-Cyprium-Therapeutics-Announce-4-1-Million-Grant-from-NINDS-to-Further-Development-of-AAV-ATP7A-Gene-Therapy-for-Menkes-Disease.html
https://www.globenewswire.com//news-release/2024/01/03/2803604/28889/en/Fortress-Biotech-Announces-Closing-of-11-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2023/12/29/2802052/28889/en/Fortress-Biotech-Announces-Pricing-of-11-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2023/12/06/2791767/28889/en/Cyprium-Therapeutics-a-Fortress-Biotech-Subsidiary-Company-Completes-Asset-Transfer-of-CUTX-101-Copper-Histidinate-Product-Candidate-for-Treatment-of-Menkes-Disease-to-Sentynl-Ther.html
https://www.globenewswire.com//news-release/2023/11/14/2780529/28889/en/Fortress-Biotech-Reports-Third-Quarter-2023-Financial-Results-and-Recent-Corporate-Highlights.html